Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Maxillary Sinus Disease in Hong Kong
Total 0 results
Nothing found
Sponsors and Collaborators
The Affiliated Hospital of Xuzhou Medical University
Salena Killion
UNITI Consortium
Defence Services Medical Academy (DSMA), Myanmar
Huisartspraktijk Handellaan
Vivid Pharma Inc.
Hungarian Dental Association
Cogniciti
Shanghai GeneChem Co., Ltd.
Zhongda Hospital, Medical School, Southeast University
NERv Technology Inc
BioNova Pharmaceuticals (Shanghai) LTD.
Nutrabolt
Université de Genève (UNIGE)
Smart Meter Corporation
Impulse Dynamics, Inc.
Health Information Technology Solutions (HITS) LLC
Ministry of Public Health, Cameroon
HBSA
Pia Jaeger, MD, PhD
View Full List
Medical Conditions
Cerebral Arterial Disease
PET-CT Specimen Imager
SMA - Spinal Muscular Atrophy
Infection, Bacterial
Alzheimer Disease Focal
Cardiovascular Primary Prevention
Research Mentoring Skills
Endoleaks
Advanced Bladder Carcinoma
Pain, Breakthrough
Vertebral Compression Fractures in Osteoporotic Patients
Immediate Implant Placement
Eye Disease, Hereditary
Premature Rupture of Membranes Prolonged
Old Age (Focus; Not a Recognized Condition)
PPA Syndrome
Biomarkers, Pharmacological
VEXAS Syndrome
Radiofrequency Ablation Treatment
Failed Induction
View Full List
Drug Interventions
TQB2450
0.75% Ropivacaine
HPN328
CNTO 6785 50 mg
Cefadroxil until drain removal
Phase B: Triplixam / Elestar HCT
Lacosamide
OXP005
5 FU continuous
Microneedling with topical glycolic acid 35%.
Olopatadine hydrochloride 0.2%
Durvalumab + chemotherapy treatment
80% oxygen
18F-FDG
Acetylsalicylic acid
20 mg/kg IV FL-301
INT-747
Rosuvastatin
CJ-12420 200mg + Clarithromycin 500mg
Oxymorphone hydrochloride (HCl)
View Full List
CROs by country
Contract Research Organizations in Algeria
Contract Research Organizations in Austria
Contract Research Organizations in Bulgaria
Contract Research Organizations in China
Contract Research Organizations in India
Contract Research Organizations in Indonesia
Contract Research Organizations in Italy
Contract Research Organizations in Latvia
Contract Research Organizations in Liberia
Contract Research Organizations in Mongolia
Contract Research Organizations in Oman
Contract Research Organizations in Slovenia
Contract Research Organizations in Togo
CRO list by country
CROs in Cambodia
SGS
Lucerent
All CROs in Cambodia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe